Our data show that tumor-infiltrating CD8+ T cells in HPV-positive tumor samples not only were more frequent but also had a higher capacity to produce IFNγ and IL-17 upon PMA and ionomycin stimulation compared to HPV-negative tumors, indicating a stronger immune response. The gene discussed is CD8A; the disease is neoplasm.